Home - Products - Others - Other Targets - Methyl cyclohexanecarboxylate

Methyl cyclohexanecarboxylate

CAS No. 4630-82-4

Methyl cyclohexanecarboxylate( Hexahydrobenzoic acid methyl ester | Methyl hexahydrobenzoate )

Catalog No. M27564 CAS No. 4630-82-4

Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 36 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methyl cyclohexanecarboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis.
  • Description
    Methyl cyclohexanecarboxylate is an endogenous metabolite and used as a material for chemical synthesis. Methyl cyclohexanecarboxylate is a flavouring ingredient with berry, estery, and fruity tasting.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Hexahydrobenzoic acid methyl ester | Methyl hexahydrobenzoate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Bacterial|β-Lactamase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4630-82-4
  • Formula Weight
    142.198
  • Molecular Formula
    C8H14O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (703.23 mM)
  • SMILES
    COC(=O)C1CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Arakawa, Yoshichika, et al.β-LACTAMASE INHIBITOR. WO2019221122A1.
molnova catalog
related products
  • MALONIC ACID, (P-HYD...

    MALONIC ACID, (P-HYDROXYBENZYL)- (7CI) is a natural product.

  • Difurazon hydrochlor...

    Difurazon hydrochloride is a mutagenic drug . Difurazon hydrochloride may has been used to treat bacillary dysentery. It is an antibacterial growth promoter in animal feeds.

  • VK-II-86

    VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.